Search
Search
Close this search box.

CBD market to see massive growth by 2028

New analysis shows that the CBD market will see massive growth in the coming years as the compound’s use gains popularity for issues such as anxiety and sleep.

A report recently released by Grand View Research said that the global CBD market size was valued at $2.8bn in 2020 and is expected to expand at a CAGR of 21.2% from 2021 to 2028.

CBD oil is used for issues such as anxiety and depression treatment, stress relief, diabetes prevention, pain relief, cancer symptom relief, and inflammation, and due to this increasing adoption, the global CBD market is anticipated to grow at a lucrative rate over the forecast period.  The report highlights that the hemp segment dominated the market and accounted for the largest revenue share of 59.6% in 2020.

Massive demand for CBD

The popularity of hemp-derived products has exploded in recent years, and this interest is expected to continue to rise in the years to come. Competition in the global market is high because companies are focused on increasing their product offerings, entering new markets, and gaining new consumers. 

Due to its many applications, the demand for CBD for health and wellness purposes is increasing, which Grand View Research says is the major factor driving the market growth, and that the rising acceptance and use of products due to government approvals is a major factor expected to boost production for CBD-infused products. 

The increasing acceptance of refined CBD products combined with the increasing legalisation of cannabis and cannabis-derived products for various medical applications is driving the growth of the segment. 

Grand View Research remarked: “Cannabidiol derived from hemp is anticipated to witness rapid growth owing to increasing demand from the pharmaceutical sector and rising awareness among consumers regarding health. 

“Increasing consumer disposable income along with the legalisation of medicinal cannabis is anticipated to have a positive impact on the demand for cannabidiol in the pharmaceutical sector. 

“Oils, tinctures, concentrate, capsules, topical solutions such as slaves, lip balms, lotions, and edibles such as baked goods, coffee, chocolates, gums, and candies are some of the CBD products which are in high demand.  

“Furthermore, the use of hemp-derived CBD is increasing rapidly owing to its anti-inflammatory, anti-aging, and antioxidant properties. Various industries such as pharmaceuticals, personal care and cosmetics, nutraceuticals, and food and beverages are developing CBD-derived products for health and wellness purposes. Therefore, the above-mentioned factors would be responsible for this segment’s fastest growth rate over the forecast period.”

For the full report please visit www.grandviewresearch.com/industry-analysis/cannabidiol-cbd-market.

🔒 Risk Management Report • Produced in partnership with RELM
Prohibition Partners RELM
📊 New Report Available Now

Relm Risk Briefing: Cannabis 2026

The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.

What's covered

  • 🌱 Cultivation risk management — biological contamination, environmental instability, and security protocols
  • ⚗️ Manufacturing & extraction — GMP standards, in-house testing, and quality control measures
  • 🔬 Testing & compliance — rigorous protocols ensuring product safety and regulatory adherence
  • 📦 Distribution & logistics — GDP-aligned transport, route monitoring, and cargo insurance
Key focus areas
Cultivation Manufacturing Testing & QC Packaging Distribution Retail & Pharmacy
100% free • Comprehensive risk analysis

Key insights

Industry Maturity Cannabis has evolved from patchwork markets to international enterprise, with risk management now the measure of long-term stability.
Cultivation Challenges Operators addressing biological contamination through controlled-environment agriculture, tissue culture, and IPM protocols.
Quality Control GMP adherence, in-house testing, and selective supplier relationships emerging as critical control points.
Supply Chain Security GDP-aligned transport, route monitoring, and comprehensive insurance remain essential safeguards.
Market Access Initiatives stabilizing domestic supply and expanding pharmacy training improving patient and consumer access.
Produced by Prohibition Partners in collaboration with RELM—the only insurer dedicated to emerging industries like cannabis.
Partnership
Produced by Prohibition Partners in collaboration with RELM

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?